NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Amid Nasdaq’s Worst Week in a Year, Three New Listings Stand Out

Two biotech IPOs and an AI infrastructure stock rose sharply on their early trading days even as the Nasdaq tumbled on broader tech weakness.

Amid Nasdaq’s Worst Week in a Year, Three New Listings Stand Out
Credit: Iambic Therapeutics
Already have an account? Sign in.
10/16/2026 · 4:42 PM
IAM
/ Read more

Feed↓

Novartis Ends Mid-Stage Fabhalta Trial in Lupus Nephritis Citing Strategic Considerations
Featured/ 10/16/2026 · 3:01 PM

Novartis Ends Mid-Stage Fabhalta Trial in Lupus Nephritis Citing Strategic Considerations

The drug remains approved for other kidney diseases.

/ Subscriber only
Tesla-SpaceX Merger Odds Top 50% as Barclays Sees Possible Deal Before December Meeting
Featured/ 10/16/2026 · 12:05 PM

Tesla-SpaceX Merger Odds Top 50% as Barclays Sees Possible Deal Before December Meeting

Kalshi traders now price in a greater-than-even chance of a Tesla–SpaceX merger by spring 2027 following the Roadster debut.

/ Subscriber only
NiSource, Microsoft Sign 20-Year Energy Agreement Expected to Deliver $1.75 Billion in Customer Savings
10/16/2026 · 11:28 AM

NiSource and Microsoft Reach Long-Term Power Deal for Northwest Indiana Data Center

Microsoft will fund new generation, raising projected NIPSCO customer savings to $1.75 billion.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI